Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-24

Clinical Trial Update: Mechanistic Investigation Of Intestinal Cytochrome p450 3A4 Following Roux-en-Y Surgery And Its Effect on Plasma Concentrations of Buspirone [Phase 4]

View source ↗

Summary

Phase 4 trial investigating how Roux-en-Y gastric bypass affects intestinal CYP3A4 activity and plasma concentrations of buspirone; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone (buspirone)

Snippet

Sponsor: North Dakota State University | Conditions: Gastric Bypass | Phase 4 | Status: TERMINATED